Acetyl L-Carnitine Slows Decline in Younger Patients With Alzheimer's Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Study Using the Trilinear Approach
Open Access
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in International Psychogeriatrics
- Vol. 10 (2) , 193-203
- https://doi.org/10.1017/s1041610298005304
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's diseaseNeurology, 1996
- A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's DiseaseJAMA, 1994
- Cognitive Decline in Alzheimer’s Disease: Elaborating on the Nature of the Longitudinal Factor Structure of the Mini-Mental State ExaminationInternational Psychogeriatrics, 1993
- The Methodology of Studying Decline in Alzheimer's DiseaseJournal of the American Geriatrics Society, 1993
- Double-blind Parallel Design Pilot Study of Acetyl Levocarnitine in Patients With Alzheimer's DiseaseArchives of Neurology, 1992
- Acetyl‐l‐Carnitine: A Drug Able to Slow the Progress of Alzheimer's Disease?Annals of the New York Academy of Sciences, 1991
- Long‐term acetyl‐L‐carnitine treatment in Alzheimer's diseaseNeurology, 1991
- Monitoring Progression in Alzheimer's DiseaseJournal of the American Geriatrics Society, 1991
- Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving ratsNeuroscience Letters, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984